Details for Patent: 11,312,698
✉ Email this page to a colleague
Which drugs does patent 11,312,698 protect, and when does it expire?
Patent 11,312,698 protects AKYNZEO and is included in one NDA.
This patent has sixty-seven patent family members in forty-nine countries.
Drugs Protected by US Patent 11,312,698
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | POWDER;INTRAVENOUS | 210493-001 | Apr 19, 2018 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| Helsinn Hlthcare | AKYNZEO | fosnetupitant chloride hydrochloride; palonosetron hydrochloride | SOLUTION;INTRAVENOUS | 210493-002 | May 27, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,312,698
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2785706 | ⤷ Sign Up | 301047 | Netherlands | ⤷ Sign Up |
| European Patent Office | 2785706 | ⤷ Sign Up | CA 2020 00028 | Denmark | ⤷ Sign Up |
| European Patent Office | 2785706 | ⤷ Sign Up | PA2020510 | Lithuania | ⤷ Sign Up |
| European Patent Office | 2785706 | ⤷ Sign Up | LUC00158 | Luxembourg | ⤷ Sign Up |
| European Patent Office | 2785706 | ⤷ Sign Up | 2020C/516 | Belgium | ⤷ Sign Up |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
